Jardiance (Empagliflozin) is a medication prescribed to diabetics to help lower blood sugar levels. One of the secondary effects is that it can help people lose weight, so doctors often prescribe Jardiance for weight loss off-label even though it is not FDA approved.
The recent four injunctions restrain domestic drugmakers from infringing the Patent of Linagliptin marketed under the trade name, ‘Trajenta’, in the country
A study conducted by the University of East Anglia has found a diabetes medication that is the first to help people with heart failure and could revolutionize its treatment.
A medication originally used for patients with diabetes is the first to help people with heart failure and could revolutionise treatment, according to new research.Early research had shown that Sodium-glucose co-transporter-2 (SGLT2) inhibitors .